Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000104 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 2, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
75,000
Total Value
$2,285,593.27
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Oct 1, 2026 | Exercise/Conversion | 25,000 | $7.80 | $195,000.00 | 948,128 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 1, 2026 | Sale | 16,246 | $83.40 | $1,354,882.28 | 931,882 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 1, 2026 | Sale | 8,554 | $84.03 | $718,754.98 | 923,328 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 1, 2026 | Sale | 200 | $84.78 | $16,956.00 | 923,128 | Direct | โ | View Details | |
Director | Employee Warrant (right to buy) | Derivative | Oct 1, 2026 | Exercise/Conversion | 25,000 | $0.00 | $0.00 | 1,528,513 | Direct | โ | View Details |